Abstract:
Summary. Atrial fibrillation (AF) is the most common
sustained cardiac arrhythmia encountered in everyday
clinical practice. Our understanding of the pathophysiology
of AF has increased dramatically over the
past few decades. Recent treatment guidelines have
heightened our awareness of the challenges involved in
the treatment of AF and provided useful recommendations
for its diagnosis and management. Because AF is
usually associated with multiple comorbid conditions,
greater emphasis must be placed on individualizing
treatment. This review focuses on current treatment
guidelines for patients with AF, assessing the benefits
and shortcomings of current pharmacologic options
and discussing new agents and trials that may provide
better opportunities to improve and individualize patient
management.
Description:
Conferinţa naţională în medicina internă din Republica Moldova cu participare internaţională, 19-20 mai 2011, Chişinău, Republica Moldova
